Pharmesis International Ltd. (SG:BFK) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Pharmesis International Ltd., a Singapore-based company specializing in health and pharmaceutical products, has announced the launch of its FDA-certified Infinity Wolfberry series through its subsidiary, Chengdu Kinna Pharmaceutical Co., Ltd. These products, which include various wolfberry-based items, are part of the company’s strategy to target overseas markets and promote a healthy lifestyle. The Infinity Wolfberry series garnered significant interest at the Western Health Pharmaceutical Ingredients and Health Products Exhibition in California, connecting Kinna with over a hundred potential customers.
For further insights into SG:BFK stock, check out TipRanks’ Stock Analysis page.